Medication | All PH-COPDa (N = 25,975) | RHCa (N = 2325) | PFTa (N = 2995) |
---|---|---|---|
Any COPD medication | 17,765 (100%) | 1670 (100%) | 2100 (100%) |
Short-acting beta agonistb | 13,083 (73.6%) | 1203 (72.0%) | 1472 (70.1%) |
Short-acting anticholinergicb | 5692 (32.0%) | 478 (28.6%) | 516 (24.6%) |
Long-acting beta agonistb | 6674 (37.6%) | 634 (38.0%) | 761 (36.2%) |
Long-acting anticholinergicb | 4756 (26.8%) | 448 (26.8%) | 388 (18.5%) |
Inhaled corticosteroidb | 14,906 (83.9%) | 1393 (83.4%) | 1788 (85.1%) |
PDE4 inhibitor | 367 (2.1%) | 35 (2.1%) | 19 (0.9%) |
Fixed-dose combination | |||
Bronchodilator/ inhaled corticosteroid | 7530 (42.4%) | 743 (44.5%) | 884 (42.1%) |
Bronchodilator/bronchodilator | 2709 (15.2%) | 290 (17.4%) | 260 (12.4%) |
Triple therapyc | 880 (5.0%) | 82 (4.9%) | 58 (2.8%) |